Novo Nordisk A/S

( )
NVO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.40%160.110.7%$1208.66m
PFEPfizer Inc. 0.08%37.190.9%$1005.03m
MRKMerck & Co., Inc. 0.00%76.430.7%$966.72m
ABBVAbbVie, Inc. -0.86%106.001.9%$820.34m
BMYBristol-Myers Squibb Co. 0.41%63.841.0%$725.84m
LLYEli Lilly & Co. 0.33%183.131.1%$599.57m
AZNAstraZeneca Plc 1.32%49.841.2%$440.69m
GSKGlaxoSmithKline Plc 0.24%36.130.2%$179.07m
RPRXRoyalty Pharma Plc 1.67%42.120.2%$163.20m
NVSNovartis AG 0.16%86.750.2%$149.07m
VTRSViatris, Inc. 1.85%13.210.0%$129.35m
RGENRepligen Corp. -3.56%205.296.8%$87.69m
CVACCureVac NV 7.28%102.610.0%$83.02m
ATNF180 Life Sciences Corp. -3.06%10.460.0%$62.67m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.94%74.920.0%$61.28m

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.